Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20200051 15.06.2020
Status
Published
(180) Expiration Date
(20) Filing Number and Date
BN N/2020/0051 14.12.2019
(40) Publication Number and Date
BN N/2020/0051
A
15.06.2020
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US 62/608,644
21.12.2017
(71/73) Applicant
(72) Inventor
(EN) ALSINA-FERNANDEZ, Jorge
(EN) COSKUN, Tamer
(EN) GUO, Lili
(EN) QU, Hongchang
(74) Representative Name
(EN) Spruson & Ferguson Pte Ltd : c/o Ahmad Isa & Partners Unit 404-A-410A 4th Floor,Wisma Jaya Jalan Pemancha Bandar Seri Begawan BS8811 Brunei Darussalam
(54) Title
(EN) INCRETIN ANALOGS AND USES THEREOF
(57) Abstract
(EN)
Incretin analogs are provided that have activity at each of the GIP, GLP-1 and glucagon receptors. The incretin analogs have structural features resulting in balanced activity and extended duration of action at each of these receptors. Methods also are provided for treating diseases such as diabetes mellitus, dyslipidemia, fatty liver disease, metabolic syndrome, non-alcoholic steatohepatitis and obesity.
(58) Citations